Loading people...
Isabelle de Cremoux is the CEO and Managing Partner of Seventure Partners, based in Paris, France. Before joining the firm in 2001 to establish its Life Sciences department, she worked in business development at Pfizer and financial auditing. She currently oversees more than €900 million in assets under management across the firm's investment vehicles. De Cremoux also created the specialized Health for Life Capital funds, which raised €250 million for its second iteration in 2019 with backing from corporate investors including Danone and Novartis. Her historical investment portfolio features notable transactions such as the $450 million sale of Santaris to Roche and the Euronext Paris initial public offering of MaaT Pharma. An engineering graduate of École Centrale Paris, de Cremoux focuses her current investment strategy on biotechnology, personalized nutrition, and the human microbiome.
Isabelle de Cremoux stands as a prominent figure in the European venture capital landscape, serving as the Managing Partner at Seventure Partners. Her leadership has been instrumental in positioning Seventure as a pioneering firm, particularly renowned for its deep expertise and significant investments in the life sciences sector, alongside a strong presence in digital technologies.
As Managing Partner, Isabelle de Cremoux is responsible for overseeing Seventure Partners' overall strategy, fund management, and investment decisions. She plays a crucial role in identifying and nurturing groundbreaking companies that are poised to make a significant impact on global health and technology. Her vision guides the firm's commitment to supporting innovative entrepreneurs and scientific breakthroughs, driving both financial returns and societal benefit.
Isabelle's investment focus areas are primarily centered around life sciences, with a particular emphasis on health, nutrition, and the burgeoning microbiome sector. Seventure Partners, under her guidance, has become a global leader in microbiome investments, recognizing its transformative potential across various industries, from human health to agriculture. Beyond life sciences, she also directs investments into promising digital technology companies, understanding the convergence of digital innovation with traditional sectors. Her expertise spans areas like digital health, biotech, medtech, and sustainable technologies.
Her distinguished career background provides a strong foundation for her leadership in venture capital. Isabelle de Cremoux holds a Ph.D. in Molecular Biology, a testament to her profound scientific understanding. This scientific rigor, combined with extensive experience in venture capital, allows her to critically evaluate complex scientific and technological propositions. She joined Seventure Partners in 2001 and steadily rose through the ranks, demonstrating exceptional acumen and strategic foresight, culminating in her appointment as Managing Partner. Her journey from a scientific background to a top leadership role in venture capital highlights her unique ability to bridge the gap between scientific discovery and commercial success.
Under Isabelle de Cremoux's leadership, Seventure Partners has built an impressive portfolio of companies. While specific individual investments she has led are numerous, the firm's overall portfolio reflects her strategic direction. Notable areas of investment include companies advancing novel therapeutics, diagnostics, and nutritional solutions, particularly within the microbiome space. Her influence has helped Seventure back companies that are not only scientifically sound but also possess strong market potential, contributing to significant advancements in health and technology globally. Her commitment to fostering innovation continues to shape the future of venture capital in Europe and beyond.
Isabelle de Cremoux is the Managing Partner at Seventure Partners, a leading European venture capital firm known for its investments in life sciences and digital technologies.
Isabelle de Cremoux primarily invests in life sciences, with a strong focus on health, nutrition, and the microbiome sector. She also directs investments into digital technologies, including digital health.
Isabelle de Cremoux works as the Managing Partner at Seventure Partners, a prominent European venture capital firm.
